Steadybase.

Pulsenmore Ltd.

Website
  • PLSM ยท Nasdaq
  • Surgical & Medical Instruments & Apparatus
  • Israel, Israel
  • 63 employees
  • CIK 0002064764

Updated from SEC filings through

Top things to know

Executives

Pulsenmore Ltd. is a U.S. public company in surgical & medical instruments & apparatus (SIC 3841), headquartered in Israel, Israel. It trades as PLSM on Nasdaq. Revenue was $12.5M in the fiscal year ending December 31, 2025. It reported about 63 employees. Elazar Sonnenschein is Chief Executive Officer.

Five-year financials

MetricFY2025
Revenue $12.5M
20-F, 2026-03-30
Operating income Not on file
SG&A Not on file
Net income -$5.0M
20-F, 2026-03-30

Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.

Leadership and board

NameTitleSource
Elazar Sonnenschein Chief Executive Officer Form 3, March 18, 2026
Eran Hirsh Chief Financial Officer Form 3, March 18, 2026
David Woods Chief Commercial Officer Form 4, October 21, 2026
Meir Shmouely VP Software Development Form 3, March 18, 2026
Michael Hamelsdorf
General Counsel & Company Secretary at Pulsenmore Ltd. - Master of Law - LLM at Bar-Ilan University
GC & Corporate Secretary Form 3, March 18, 2026
Minelu Sonnenschein VP R&D Form 3, March 18, 2026

What Pulsenmore Ltd. does

Pulsenmore (NASDAQ and TASE: PLSM) is a world leader in self-scan ultrasound devices for remote clinical diagnosis and screening.

Company website description, 10-K for the year ending November 7, 2026

Shares and governance

Shares outstanding 6.5 million (as of March 15, 2026) 20-F, March 30, 2026
Auditor Kesselman & Kesselman (Tel-Aviv, Israel) Latest 10-K

Insider trades

Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.

DateInsiderTradeSharesValueSource
November 4, 2026 Elazar Sonnenschein
Chief Executive Officer
Buy 9,259 $16K Form 4, November 5, 2026

Recent 8-K events

No 8-K filings on file.

Frequently asked questions about Pulsenmore Ltd.

What does Pulsenmore Ltd. do?
In its own words, from Item 1 of its 10-K: "Pulsenmore (NASDAQ and TASE: PLSM) is a world leader in self-scan ultrasound devices for remote clinical diagnosis and screening."
What is Pulsenmore Ltd.'s revenue?
$12.5M for the fiscal year ending December 31, 2025, from its 20-F filed March 30, 2026.
Is Pulsenmore Ltd. profitable?
Pulsenmore Ltd. reported net income of -$5.0M for the fiscal year ending December 31, 2025.
How many employees does Pulsenmore Ltd. have?
About 63 as of December 31, 2025, as stated in its annual report.
Who is the CEO of Pulsenmore Ltd.?
Elazar Sonnenschein, Chief Executive Officer, as named in a 3 filed March 18, 2026.
Who is the CFO of Pulsenmore Ltd.?
Eran Hirsh, Chief Financial Officer, as named in a 3 filed March 18, 2026.
Where is Pulsenmore Ltd. headquartered?
Israel, Israel.
What is Pulsenmore Ltd.'s stock ticker?
PLSM on Nasdaq.
What industry is Pulsenmore Ltd. in?
Surgical & Medical Instruments & Apparatus, SIC code 3841.
What is Pulsenmore Ltd.'s website?
pulsenmore.com.
Is Pulsenmore Ltd. a public company?
Yes. Pulsenmore Ltd. files with the SEC under CIK 0002064764 and trades as PLSM.
Who audits Pulsenmore Ltd.?
Kesselman & Kesselman, Tel-Aviv, Israel, as named in its latest annual report (10-K).
How many shares of Pulsenmore Ltd. are outstanding?
6.5 million shares as of March 15, 2026, from its 20-F filed March 30, 2026.
Have Pulsenmore Ltd. insiders traded stock recently?
Since November 4, 2026, officers and directors reported 0 open-market sales and 1 purchase worth about $16K on Forms 4 and 5. The most recent: Elazar Sonnenschein (Chief Executive Officer) bought 9,259 shares on November 4, 2026.